Global, multicenter, open-label, randomized phase II trial comparing gemcitabine (G) with. G plus AGS-1C4D4 (A) in patients (pts) with metastatic pancreatic cancer (mPC). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Wolpin, BM
  • O'Reilly, EM
  • Ko, Y
  • Blaszkowsky, LS
  • Rarick, MU
  • Lima, CMS Rocha
  • Ritch, PS
  • Chan, E
  • Spratlin, JL
  • Macarulla, T
  • McWhirter, Elaine
  • Pezet, D
  • Lichinitser, M
  • Roman, LD
  • Hartford, A
  • Jackson, L
  • Vincent, M
  • Reyno, LM
  • Hidalgo, M

publication date

  • May 20, 2011